Dana Dobešová

Ms. Dana Dobešová

Palacký University, Olomouc, Olomouc, Olomoucký Kraj, Czech Republic
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2022 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Open access
Aleš KvasničkaAleš Kvasnička
Aleš Kvasnička
Lukáš NajdekrLukáš Najdekr
Lukáš Najdekr
DDDana Dobešová
Dana Dobešová
BPBarbora Piskláková
Barbora Piskláková
EIEliška Ivanovová
Eliška Ivanovová
DFDavid Friedecky
David Friedecky
Lipidomics as a branch of metabolomics provides unique information on the complex lipid profile in biological materials. In clinically focused studies, hundreds of lipids together with available clinical information proved to be an effective tool in the discovery of biomarkers and understanding of pathobiochemistry. However, despite the introduction of lipidomics nearly twenty years ago, only dozens of big data studies using clinical lipidomics have been published to date. In this review, we discuss the lipidomics workflow, statistical tools, and the challenges of standartisation. The consequent summary divided into major clinical areas of cardiovascular disease, cancer, diabetes mellitus, neurodegenerative and liver diseases is demonstrating the importance of clinical lipidomics. In these publications, the potential of lipidomics for prediction, diagnosis or finding new targets for the treatment of selected diseases can be seen. The first of these results have already been implemented in clinical practice in the field of cardiovascular diseases, while in other areas we can expect the application of the results summarized in this review in the near future.

1 November 2021 in Microchemical Journal
Verified
Journal Article
Closed access
EIEliška Ivanovová
Eliška Ivanovová
BPBarbora Piskláková
Barbora Piskláková
DDDana Dobešová
Dana Dobešová
Aleš KvasničkaAleš Kvasnička
Aleš Kvasnička
DFDavid Friedecky
David Friedecky

20 January 2024 in Talanta
Verified
Journal Article
Closed access
EIEliška Ivanovová
Eliška Ivanovová
BPBarbora Piskláková
Barbora Piskláková
DDDana Dobešová
Dana Dobešová
HJHana Janečková
Hana Janečková
HFHana Foltenová
Hana Foltenová
DFDavid Friedecky
David Friedecky

13 March 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
LMLucie Mádrová
Lucie Mádrová
OSOlga Součková
Olga Součková
RBRadana Brumarová
Radana Brumarová
DDDana Dobešová
Dana Dobešová
JVJan Václavík
Jan Václavík
Tomáš AdamTomáš Adam
Tomáš Adam
Three genetically determined enzyme defects of purine de novo synthesis (PDNS) have been identified so far in humans: adenylosuccinate lyase (ADSL) deficiency, 5-amino-4-imidazole carboxamide-ribosiduria (AICA-ribosiduria), and deficiency in bifunctional enzyme phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase (PAICS). Clinical signs of these defects are mainly neurological, such as seizures, psychomotor retardation, epilepsy, autistic features, etc. This work aims to describe the metabolic changes of CRISPR-Cas9 genome-edited HeLa cells deficient in the individual steps of PDNS to better understand known and potential defects of the pathway in humans. High-performance liquid chromatography coupled with mass spectrometry was used for both targeted and untargeted metabolomic analyses. The statistically significant features from the untargeted study were identified by fragmentation analysis. Data from the targeted analysis were processed in Cytoscape software to visualize the most affected metabolic pathways. Statistical significance of PDNS intermediates preceding deficient enzymes was the highest (p-values 10 × 10−7–10 × 10−15) in comparison with the metabolites from other pathways (p-values of up to 10 × 10−7). Disturbed PDNS resulted in an altered pool of adenine and guanine nucleotides. However, the adenylate energy charge was not different from controls. Different profiles of acylcarnitines observed among deficient cell lines might be associated with a specific enzyme deficiency rather than global changes related to the PDNS pathway. Changes detected in one-carbon metabolism might reduce the methylation activity of the deficient cells, thus affecting the modification state of DNA, RNA, and proteins.

18 February 2025 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Open access
JSJana Schwarzerova
Jana Schwarzerova
EMErdő Gabor Mate
Erdő Gabor Mate
JIJakub Idkowiak
Jakub Idkowiak
DODominika Olešová
Dominika Olešová
Aleš KvasničkaAleš Kvasnička
Aleš Kvasnička
TNThomas Nägele
Thomas Nägele

1 January 2023 in Stat
Verified
Journal Article
Open access
NSNikola Stefelova
Nikola Stefelova
JSJulie de Sousa
Julie de Sousa
KHKarel Hron
Karel Hron
JPJavier Palarea-Albaladejo
Javier Palarea-Albaladejo
DDDana Dobešová
Dana Dobešová
DFDavid Friedecky
David Friedecky
Data resulting from high‐throughput biological experiments are frequently of relative nature. This implies that the most relevant information is on the shape of the data distribution over the biological features more than on the size of the measurements themselves. One well‐established way to acknowledge this in statistical processing is through logratio analysis. In the current work, we introduce selective pivot logratio coordinates as a new type of orthonormal logratio coordinate representation for high‐dimensional relative (a.k.a. compositional) data. This proposal is aimed to enhance the identification of biomarkers in the context of binary classification problems, which is a common setting of scientific studies in the field. These logratio coordinates are constructed so that the pivot coordinate representing a certain compositional part aggregates all pairwise logratios of that part to the rest but, unlike in the ordinary formulation, excludes those deviating from the main pattern. This novel coordinate system is embedded within a partial least squares discriminant analysis (PLS‐DA) model for its practical application. Based on both synthetic and real‐world metabolomic data sets, we demonstrate the enhanced performance of the novel approach when compared with other methods used in the area.